Discover
ALGS
Aligos Therapeutics, Inc.
5.15
1 x 5.00
1 x 6.40
bid
ask
-
0.29
5.33%
118 @ 04:49 PM
5.08 -0.07 (1.36%)
| Ytd | -44.74% | |
| 1y | -43.53% |
5.08
day range
5.50
6.76
52 week range
42.95
| Open | 5.36 | Prev Close | 5.44 | Low | 5.08 | High | 5.50 | Mkt Cap | 141.15M |
| Vol | 58.14K | Avg Vol | 354.61K | EPS | -7.25 | P/E | -0.59 | Forward P/E | -3.30 |
| Beta | 2.12 | Short Ratio | 0.50 | Inst. Own | 48.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 19.24 | 200-d Avg | 16.32 | 1yr Est | 103.33 |
| Income Statement | |||
| Total Revenue | 2.83M | ||
| Revenues (USD) | 2.83M | ||
| Gross Profit | 2.83M | ||
| Operating Expenses | 29.76M | ||
| Research and Development Expense | 23.35M | ||
| Selling, General and Administrative Expense | 6.41M | ||
| Operating Income | -26.93M | ||
| Interest Expense | -811.00K | ||
| Income Tax Expense | 317.00K | ||
| Net Income | -23.04M | ||
| Net Income Common Stock | -23.04M | ||
| Net Income Common Stock (USD) | -23.04M | ||
| Consolidated Income | -23.04M | ||
| Earnings per Basic Share | -2.21 | ||
| Earnings per Basic Share (USD) | -2.21 | ||
| Earnings per Diluted Share | -2.21 | ||
| Earning Before Interest & Taxes (EBIT) | -23.53M | ||
| Earning Before Interest & Taxes (USD) | -23.53M | ||
| Weighted Average Shares | 10.40M | ||
| Weighted Average Shares Diluted | 10.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 30.15M | ||
| Cash and Equivalents (USD) | 30.15M | ||
| Investments | 24.93M | ||
| Investments Current | 24.93M | ||
| Current Assets | 59.63M | ||
| Property, Plant & Equipment Net | 4.17M | ||
| Total Assets | 64.56M | ||
| Debt Current | 3.69M | ||
| Total Debt | 4.35M | ||
| Current Liabilities | 23.32M | ||
| Debt Non-Current | 659.00K | ||
| Total Liabilities | 32.77M | ||
| Accumulated Retained Earnings (Deficit) | -665.24M | ||
| Accumulated Other Comprehensive Income | 438.00K | ||
| Shareholders Equity | 31.79M | ||
| Shareholders Equity (USD) | 31.79M | ||
| Assets Non-Current | 4.93M | ||
| Total Debt (USD) | 4.35M | ||
| Liabilities Non-Current | 9.45M | ||
| Trade and Non-Trade Payables | 7.64M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 855.00K | ||
| Net Cash Flow from Financing | -62.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 11.74M | ||
| Capital Expenditure | -69.00K | ||
| Issuance (Repayment) of Debt Securities | -62.00K | ||
| Net Cash Flow from Investing | 34.93M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 35.00M | ||
| Net Cash Flow from Operations | -23.13M | ||
| Share Based Compensation | 1.31M | ||